Finch Therapeutics Group, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LAKE STREET ADVISORS GROUP, LLC | 08/05/2024 | 21.21 K | $29.05 K | 0.00% | 1.32% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| VANGUARD GROUP INC | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK INC. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| BLEICHROEDER LP | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
Finch Therapeutics Group, Inc. institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of Finch Therapeutics Group, Inc.. The most heavily invested institutionals were:
BlackRock Inc.: 0
Avenir Management Company, LLC: 45,650
Amalgamated Financial Corp.: 942
FIRST MIDWEST BANK TRUST DIVISION: 0
1.32% of Finch Therapeutics Group, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 46.59 K shares in the last 24 months. This purchase volume represents approximately $83.87 K in transactions.